Is Eiko Lifescience overvalued or undervalued?
As of June 27, 2025, Eiko Lifescience is considered overvalued with a PE ratio of 46.97 and a year-to-date decline of 19.13%, significantly higher than its peers and indicating it may not justify its current price.
As of 27 June 2025, Eiko Lifescience has moved from a fair to an expensive valuation grade. The company is currently overvalued based on its high valuation ratios, including a PE ratio of 46.97, an EV to EBITDA of 35.01, and a PEG ratio of 0.70. These figures suggest that the stock is trading at a premium compared to its earnings growth potential.In comparison to its peers, Eiko Lifescience's PE ratio significantly exceeds that of Life Insurance, which stands at 12.53, and Bajaj Finserv at 36.79. The disparity in valuation metrics indicates that Eiko Lifescience may not justify its current price given the lower returns on capital, with a ROCE of only 2.31% and ROE of 2.63%. Additionally, the company's recent stock performance shows a year-to-date decline of 19.13%, contrasting with the Sensex's gain of 7.58%, further reinforcing the notion that Eiko Lifescience is overvalued in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
